[Behavior of hydrocolloid impression materials during disinfection for AIDS virus] NLM AIDSLINE Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Behavior of hydrocolloid impression materials during disinfection for AIDS virus]

Hell Stomatol Chron. 1989 Oct-Dec;33(4):227-34. Unique Identifier : AIDSLINE MED/91079028
Anasassiadou V; Sofou A; Laskaridis I; Kaloyiannides A

Abstract: The aim of this study is to investigate the dimensional changes of hydrocolloid impression materials agar type and alginates, when they are placed in fluids for AIDS virus sterilization as Sterile pack, alcohol 75%, sodium chloride 10% and Cidex for 40 min. It was found out that when the hydrocolloids were placed in alcoholic and Sterile pack fluids a great deal of changes happened (contraction and shrinkage) that made the sterilization in them impossible. The percentage of linear extention and imbibition noticed in hydrocolloids when they were placed in sodium chlorides and Cidex solutions showed that sterilization in them is usually possible. The best way of sterilization is to make a gypsum model from the hydrocolloid impression and place it in the furnace for 30 min in 60 degrees C.
Keywords: Acquired Immunodeficiency Syndrome/PREVENTION & CONTROL Agar/CHEMISTRY Alcohol, Ethyl Alginates/CHEMISTRY Colloids/*CHEMISTRY Dental Impression Materials/*CHEMISTRY *Disinfectants English Abstract Glutaral/CHEMISTRY HIV Sodium Chloride JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/prevention&controlagar/chemistryalcohol,ethylalginates/chemistrycolloids/KWDchemistrydentalimpressionmaterials/KWDchemistryKWDdisinfectantsenglishabstractglutaral/chemistryhivsodiumchloridejournalarticle
910430
M9140668

Copyright © 1991 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .